TrialJournal of diabetes science and technology2017

Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes.

Lisa J Underland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.